EQS-News: Lonza Group AG: Lonza Completes Divestment of Specialty Ingredients Business
Lonza Completes Divestment of Specialty Ingredients Business
02.07.2021 / 07:00
Basel, Switzerland, 2 July 2021 -
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
Albert M. Baehny, Chairman, Lonza commented: Since announcing our intention to divest the Specialty Ingredients business, we have made significant progress in consolidating our new structure and identity and refining our focus as a pure-play partner to the healthcare industry. As the divestment of the Specialty Ingredients business completes, at Lonza we have an opportunity to consolidate our identity and redouble our focus on long-term growth while delivering value for our customers, employees and shareholders.
EQS-Adhoc: IGEA Pharma N V : IGEA TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-Adhoc: IGEA TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.